Hypaque and steroids in the treatment of sudden sensorineural hearing loss

T. S. Huang, S. T. Chan, T. L. Ho, J. L. Su, F. P. Lee

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

While the origins of sudden sensorineural hearing loss remain unproven and treatment empirical, the most appropriate therapy remains a matter of controversy. In this paper we have analysed the current forms of treatment, i.e. diatrizoate meglumine, steroids and a vasodilator. The results suggest that although several related factors were shown to indicate a good prognosis regardless of the therapy, none of the currently available regimens produces consistently better results than the spontaneous recovery rate of 65% reported by Mattox & Simmons.

Original languageEnglish
Pages (from-to)45-51
Number of pages7
JournalClinical Otolaryngology and Allied Sciences
Volume14
Issue number1
Publication statusPublished - 1989
Externally publishedYes

Fingerprint

Diatrizoate
Sudden Hearing Loss
Sensorineural Hearing Loss
Steroids
Diatrizoate Meglumine
Vasodilator Agents
Therapeutics

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Hypaque and steroids in the treatment of sudden sensorineural hearing loss. / Huang, T. S.; Chan, S. T.; Ho, T. L.; Su, J. L.; Lee, F. P.

In: Clinical Otolaryngology and Allied Sciences, Vol. 14, No. 1, 1989, p. 45-51.

Research output: Contribution to journalArticle

Huang, T. S. ; Chan, S. T. ; Ho, T. L. ; Su, J. L. ; Lee, F. P. / Hypaque and steroids in the treatment of sudden sensorineural hearing loss. In: Clinical Otolaryngology and Allied Sciences. 1989 ; Vol. 14, No. 1. pp. 45-51.
@article{b67926c55a4d4928b26f3d60b58353d1,
title = "Hypaque and steroids in the treatment of sudden sensorineural hearing loss",
abstract = "While the origins of sudden sensorineural hearing loss remain unproven and treatment empirical, the most appropriate therapy remains a matter of controversy. In this paper we have analysed the current forms of treatment, i.e. diatrizoate meglumine, steroids and a vasodilator. The results suggest that although several related factors were shown to indicate a good prognosis regardless of the therapy, none of the currently available regimens produces consistently better results than the spontaneous recovery rate of 65{\%} reported by Mattox & Simmons.",
author = "Huang, {T. S.} and Chan, {S. T.} and Ho, {T. L.} and Su, {J. L.} and Lee, {F. P.}",
year = "1989",
language = "English",
volume = "14",
pages = "45--51",
journal = "Clinical Otolaryngology",
issn = "1749-4478",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Hypaque and steroids in the treatment of sudden sensorineural hearing loss

AU - Huang, T. S.

AU - Chan, S. T.

AU - Ho, T. L.

AU - Su, J. L.

AU - Lee, F. P.

PY - 1989

Y1 - 1989

N2 - While the origins of sudden sensorineural hearing loss remain unproven and treatment empirical, the most appropriate therapy remains a matter of controversy. In this paper we have analysed the current forms of treatment, i.e. diatrizoate meglumine, steroids and a vasodilator. The results suggest that although several related factors were shown to indicate a good prognosis regardless of the therapy, none of the currently available regimens produces consistently better results than the spontaneous recovery rate of 65% reported by Mattox & Simmons.

AB - While the origins of sudden sensorineural hearing loss remain unproven and treatment empirical, the most appropriate therapy remains a matter of controversy. In this paper we have analysed the current forms of treatment, i.e. diatrizoate meglumine, steroids and a vasodilator. The results suggest that although several related factors were shown to indicate a good prognosis regardless of the therapy, none of the currently available regimens produces consistently better results than the spontaneous recovery rate of 65% reported by Mattox & Simmons.

UR - http://www.scopus.com/inward/record.url?scp=0024550630&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024550630&partnerID=8YFLogxK

M3 - Article

C2 - 2920456

AN - SCOPUS:0024550630

VL - 14

SP - 45

EP - 51

JO - Clinical Otolaryngology

JF - Clinical Otolaryngology

SN - 1749-4478

IS - 1

ER -